# A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

> **NCT06226714** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **CanSino Biologics Inc.** · enrollment: 840 (actual)

## Conditions studied

- Meningococcal Meningitis

## Interventions

- **BIOLOGICAL:** MCV4
- **BIOLOGICAL:** MPSV4

## Key facts

- **NCT ID:** NCT06226714
- **Lead sponsor:** CanSino Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2024-09-26
- **Final completion:** 2025-08
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2025-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06226714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06226714, "A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06226714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*